Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on NGS Services Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on NGS Services Industry
  • 1.7 COVID-19 Impact: NGS Services Market Trends

    • 2 Global NGS Services Quarterly Market Size Analysis

    • 2.1 NGS Services Business Impact Assessment - COVID-19
      • 2.1.1 Global NGS Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global NGS Services Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global NGS Services Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, NGS Services Headquarters and Area Served
    • 3.3 Date of Key Players Enter into NGS Services Market
    • 3.4 Key Players NGS Services Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on NGS Services Segments, By Type

    • 4.1 Introduction
      • 1.4.1 RNA-Seq
      • 1.4.2 Exome
    • 4.2 By Type, Global NGS Services Market Size, 2019-2021

    5 Impact of Covid-19 on NGS Services Segments, By Application

    • 5.1 Overview
      • 5.5.1 Oncology
      • 5.5.2 Lung cancer
      • 5.5.3 Breast cancer
      • 5.5.4 Prostate cancer
      • 5.5.5 Colorectal cancer
      • 5.5.6 Others
    • 5.2 By Application, Global NGS Services Market Size, 2019-2021
      • 5.2.1 By Application, Global NGS Services Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Beijing Genomics Institute (BGI)
      • 7.1.1 Beijing Genomics Institute (BGI) Business Overview
      • 7.1.2 Beijing Genomics Institute (BGI) NGS Services Quarterly Revenue, 2020
      • 7.1.3 Beijing Genomics Institute (BGI) NGS Services Product Introduction
      • 7.1.4 Beijing Genomics Institute (BGI) Response to COVID-19 and Related Developments
    • 7.2 Cegat (Centre for Genomics and Transcriptomics) GMBH
      • 7.2.1 Cegat (Centre for Genomics and Transcriptomics) GMBH Business Overview
      • 7.2.2 Cegat (Centre for Genomics and Transcriptomics) GMBH NGS Services Quarterly Revenue, 2020
      • 7.2.3 Cegat (Centre for Genomics and Transcriptomics) GMBH NGS Services Product Introduction
      • 7.2.4 Cegat (Centre for Genomics and Transcriptomics) GMBH Response to COVID-19 and Related Developments
    • 7.3 DNA Vision SA
      • 7.3.1 DNA Vision SA Business Overview
      • 7.3.2 DNA Vision SA NGS Services Quarterly Revenue, 2020
      • 7.3.3 DNA Vision SA NGS Services Product Introduction
      • 7.3.4 DNA Vision SA Response to COVID-19 and Related Developments
    • 7.4 Eurofins Genomics Inc.
      • 7.4.1 Eurofins Genomics Inc. Business Overview
      • 7.4.2 Eurofins Genomics Inc. NGS Services Quarterly Revenue, 2020
      • 7.4.3 Eurofins Genomics Inc. NGS Services Product Introduction
      • 7.4.4 Eurofins Genomics Inc. Response to COVID-19 and Related Developments
    • 7.5 Febit / Comprehensive Biomarker Center GMBH (CBC)
      • 7.5.1 Febit / Comprehensive Biomarker Center GMBH (CBC) Business Overview
      • 7.5.2 Febit / Comprehensive Biomarker Center GMBH (CBC) NGS Services Quarterly Revenue, 2020
      • 7.5.3 Febit / Comprehensive Biomarker Center GMBH (CBC) NGS Services Product Introduction
      • 7.5.4 Febit / Comprehensive Biomarker Center GMBH (CBC) Response to COVID-19 and Related Developments
    • 7.6 Genomnia SRL
      • 7.6.1 Genomnia SRL Business Overview
      • 7.6.2 Genomnia SRL NGS Services Quarterly Revenue, 2020
      • 7.6.3 Genomnia SRL NGS Services Product Introduction
      • 7.6.4 Genomnia SRL Response to COVID-19 and Related Developments
    • 7.7 Mina Inc.
      • 7.7.1 Mina Inc. Business Overview
      • 7.7.2 Mina Inc. NGS Services Quarterly Revenue, 2020
      • 7.7.3 Mina Inc. NGS Services Product Introduction
      • 7.7.4 Mina Inc. Response to COVID-19 and Related Developments
    • 7.8 Macrogen Inc.
      • 7.8.1 Macrogen Inc. Business Overview
      • 7.8.2 Macrogen Inc. NGS Services Quarterly Revenue, 2020
      • 7.8.3 Macrogen Inc. NGS Services Product Introduction
      • 7.8.4 Macrogen Inc. Response to COVID-19 and Related Developments
    • 7.9 Microsynth AG
      • 7.9.1 Microsynth AG Business Overview
      • 7.9.2 Microsynth AG NGS Services Quarterly Revenue, 2020
      • 7.9.3 Microsynth AG NGS Services Product Introduction
      • 7.9.4 Microsynth AG Response to COVID-19 and Related Developments
    • 7.10 Seqomics
      • 7.10.1 Seqomics Business Overview
      • 7.10.2 Seqomics NGS Services Quarterly Revenue, 2020
      • 7.10.3 Seqomics NGS Services Product Introduction
      • 7.10.4 Seqomics Response to COVID-19 and Related Developments
    • 7.11 Source Bio Science
      • 7.11.1 Source Bio Science Business Overview
      • 7.11.2 Source Bio Science NGS Services Quarterly Revenue, 2020
      • 7.11.3 Source Bio Science NGS Services Product Introduction
      • 7.11.4 Source Bio Science Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of NGS Services, including the following market information:
      Global NGS Services Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global NGS Services Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global NGS Services Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global NGS Services Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics) GMBH, DNA Vision SA, Eurofins Genomics Inc., Febit / Comprehensive Biomarker Center GMBH (CBC), Genomnia SRL, Mina Inc., Macrogen Inc., Microsynth AG, Seqomics, Source Bio Science, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      RNA-Seq
      Exome

      Based on the Application:
      Oncology
      Lung cancer
      Breast cancer
      Prostate cancer
      Colorectal cancer
      Others

      Buy now